SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-039387
Filing Date
2024-02-20
Accepted
2024-02-20 08:00:57
Documents
14
Period of Report
2024-02-16
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d774101d8k.htm   iXBRL 8-K 23373
  Complete submission text file 0001193125-24-039387.txt   144368

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA kpti-20240216.xsd EX-101.SCH 2848
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE kpti-20240216_lab.xml EX-101.LAB 17995
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kpti-20240216_pre.xml EX-101.PRE 11260
15 EXTRACTED XBRL INSTANCE DOCUMENT d774101d8k_htm.xml XML 3628
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 24650798
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)